Expand AMGN Menu
AMGN MENU

AMGN Latest Press Releases

-- November 11, 2026 --

AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJGREN'S DISEASE PRNewswire 8:00 AM

-- November 9, 2026 --

NEW DATA AT AHA 2026 DEMONSTRATES THE VALUE OF TREATMENT WITH REPATHA EARLIER IN THE CARDIOVASCULAR RISK CONTINUUM PRNewswire 4:00 PM

-- November 5, 2026 --

REPATHA LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY PRNewswire 9:00 AM

-- November 3, 2026 --

AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS PRNewswire 4:01 PM

-- October 28, 2026 --

AMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTS PRNewswire 4:30 PM

-- October 27, 2026 --

AMGEN ANNOUNCES 2026 FOURTH QUARTER DIVIDEND PRNewswire 6:28 PM
AMGEN TO PRESENT NEW DATA ACROSS RARE AND OTHER SERIOUS AUTOIMMUNE DISEASES AT ACR CONVERGENCE 2026 PRNewswire 4:00 PM

-- October 26, 2026 --

AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS PRNewswire 5:54 PM

-- October 24, 2026 --

IMDELLTRA IN COMBINATION WITH IMFINZI REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER PRNewswire 10:30 AM

-- October 20, 2026 --

AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026 PRNewswire 4:15 PM
TEZSPIRE DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS PRNewswire 9:01 AM

-- September 22, 2026 --

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJGREN'S DISEASE PRNewswire 9:01 AM

-- September 14, 2026 --

FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA PRNewswire 9:00 AM

-- September 9, 2026 --

AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE PRNewswire 4:02 PM

-- September 8, 2026 --

IMDELLTRA IN COMBINATION WITH IMFINZI DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER PRNewswire 9:00 AM

-- September 2, 2026 --

AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE PRNewswire 4:01 PM

-- August 31, 2026 --

AMGEN'S REPATHA REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE PRNewswire 3:19 AM

-- August 27, 2026 --

TEZSPIRE DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS PRNewswire 2:00 AM

-- August 4, 2026 --

AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS PRNewswire 4:01 PM

-- July 30, 2026 --

AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND PRNewswire 4:01 PM

-- July 28, 2026 --

AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS PRNewswire 4:45 PM
Market Data Delayed 15 Minutes